ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617989 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617989; 2) Community: the network communities that were significantly associated with the response to NSC 617989; 3) Molecule: the relationships between components within communities and NSC 617989; 4) MDR: the compounds that were significantly associated with the NSC 617989.

NSC Compound Enrichment Correlation
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0386895225700407 0.42519133
NSC 756282 GW620972X 0.0386895225700407 0.13081534
NSC 761676 Null 0.0386895225700407 0.11925409
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0386895225700407 0.31844333
NSC 87084 Null 0.0386895225700407 0.043815928
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.0386895225700413 0.42249987
NSC 287459 Cytarabine AY 0.0386895225700413 0.40196275
NSC 295466 Null 0.0386895225700413 0.32731965
NSC 37202 Acco Naphthol AS-BO 0.0386895225700413 -0.12604549
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.0410413740044187 0.45292356
Total:184  Current:137    [First] [Prev] [Next] [Last]